Prosthetic Valve Articles & Analysis: Older
5 news found
A significant proportion of patients had endocarditis of a prosthetic valve (41% CytoSorb treated, 28% control). The study analyses focused on the comparison of the control cohort (n=101) who were treated prior to CytoSorb introduction at the hospital and the CytoSorb cohort (n=94) who received intraoperative CytoSorb therapy during the operation. ...
Scott has more than two decades of experience in the medical technology industry, including with prosthetic heart valves, heart valve repair, orthopedic surgery, stents, blood pumps, TETS, robotic prostheses / orthoses and many more. ...
Approximately 53% of BAV patients require aortic valve surgery within 25 years of being diagnosed.[1] Most BAV patients undergo aortic valve replacement between 40 and 60 years of age, subjecting them to increased risk of reoperation or complications associated with valve replacement technologies. [2] Valve repair is an ...
Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. ...
The superior design features of the Colibri TAVI System positions the product to address the variations in patient aortic valve structures, such as bicuspid valves, and also prosthetic valve mismatch as the indications for expanded use. With the addition of ISO 13485 and EN ISO 13485 certification, Colibri will be able to ...